Repare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023
Strategic Progress Amidst Financial Challenges
Source: yahoo.com
Page 13 - Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clinical Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clinical Program Today - Breaking & Trending Today
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
Total net revenue was $45.1 million and $175.5 million, and net product revenue was $42.3 million and $158.5 million, for the fourth quarter and full year 2023, respectively $350.7 million of...
Source: marketscreener.com
Viking Therapeutics Inc (VKTX) Reports Year-End Financials Highlighting Strong Cash Position ...
Key Developments and Financials from 2023 Earnings Report
Source: yahoo.com
Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in ...
Data reinforce the potential of NTLA-2002 to eliminate angioedema attacks in people living with hereditary angioedema (HAE) after a single doseA single dose of NTLA-2002 led to 95% mean reduction
Source: eagletribune.com
Takeda's HYQVIA® Approved by European Commission as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Region
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan 29, 2024--
Source: eagletribune.com